Publication: CAGE-defined promoter regions of the genes implicated in Rett Syndrome
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Vitezic, M., N. Bertin, R. Andersson, L. Lipovich, H. Kawaji, T. Lassmann, A. Sandelin, et al. 2014. “CAGE-defined promoter regions of the genes implicated in Rett Syndrome.” BMC Genomics 15 (1): 1177. doi:10.1186/1471-2164-15-1177. http://dx.doi.org/10.1186/1471-2164-15-1177.
Research Data
Abstract
Background: Mutations in three functionally diverse genes cause Rett Syndrome. Although the functions of Forkhead box G1 (FOXG1), Methyl CpG binding protein 2 (MECP2) and Cyclin-dependent kinase-like 5 (CDKL5) have been studied individually, not much is known about their relation to each other with respect to expression levels and regulatory regions. Here we analyzed data from hundreds of mouse and human samples included in the FANTOM5 project, to identify transcript initiation sites, expression levels, expression correlations and regulatory regions of the three genes. Results: Our investigations reveal the predominantly used transcription start sites (TSSs) for each gene including novel transcription start sites for FOXG1. We show that FOXG1 expression is poorly correlated with the expression of MECP2 and CDKL5. We identify promoter shapes for each TSS, the predicted location of enhancers for each gene and the common transcription factors likely to regulate the three genes. Our data imply Polycomb Repressive Complex 2 (PRC2) mediated silencing of Foxg1 in cerebellum. Conclusions: Our analyses provide a comprehensive picture of the regulatory regions of the three genes involved in Rett Syndrome. Electronic supplementary material The online version of this article (doi:10.1186/1471-2164-15-1177) contains supplementary material, which is available to authorized users.
Description
Other Available Sources
Keywords
Rett Syndrome, CAGE, Transcriptomics, Promoter architecture
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service